Latest filing published 10 Mar 2016 for Blue Biofuels, INC., €13.
Based on 78 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Daniel de Liege discloses dealings in Blue Biofuels, Inc. to SEC (Form 4). We count 136 filings; the first trade dates from 28 March 2012 and the latest from 29 January 2016.
Both buying and selling appear: 109 purchases worth €35k, against 22 sales worth €222k. Sales outweigh purchases by €187k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2016 alone, the filings show 16 purchases and no sales.
The median purchase comes to €73. Across 16 purchases, this insider has always bought alone, with no colleague buying within 30 days. Ninety days after publication, 78 purchases show a median change of -24.3%, with the price up in 49% of them. They describe history only and say nothing certain about the share price ahead.
Most recently, on 10 March 2016, the filings show an open-market purchase worth €13 in Blue Biofuels, Inc. Typically, a trade is published a median of 45 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 109 declarations